
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | 2026-05-21 | Casdin Partners Master Fund, L.P. | 10% Owner | Sale | 650.0K | $23.70 | $15.40M | 4.76M | View ↗ | |
| 2026-05-20 | 2026-05-21 | Casdin Partners Master Fund, L.P. | 10% Owner | Sale | 250.0K | $23.70 | $5.92M | 5.41M | View ↗ | |
| 2026-05-19 | 2026-05-21 | Casdin Partners Master Fund, L.P. | 10% Owner | Sale | 300.0K | $22.65 | $6.79M | 5.66M | View ↗ | |
| 2026-03-23 | 2026-03-31 | Foster Karen A. | Chief Quality and Operations | Sale | 2,577 | $19.17 | $49K | 108.8K | View ↗ | |
| 2026-03-09 | 2026-03-09 | Foster Karen A. | Chief Quality and Operations | Sale | 500 | $20.00 | $10K | 113.2K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $96.2M+28.9% | $74.6M+9.7% | $68.0M-10.8% | $76.2M-36.0% | $119.2M |
| Cost of revenue | $34.1M+38.9% | $24.6M-8.0% | $26.7M | — | $7.1M |
| Gross profit | $62.1M+24.0% | $50.1M+21.2% | $41.3M | — | — |
| General and administrative | $45.5M+12.0% | $40.6M-5.1% | $42.8M+28.7% | $33.3M-1.2% | $33.7M |
| Sales and marketing | $9.8M+10.3% | $8.9M-21.5% | $11.4M-2.5% | $11.7M-16.7% | $14.0M |
| Research and development | $7.6M+59.3% | $4.8M-13.9% | $5.5M-36.4% | $8.7M-26.6% | $11.8M |
| IPR&D expense | $15.5M | $0 | $0 | — | — |
| Intangible asset amortization | $263K+0.0% | $263K-74.5% | $1.0M-74.1% | $4.0M-51.4% | $8.2M |
| Change in fair value of contingent consideration | $0 | $0+100.0% | -$2.2M+53.9% | -$4.8M-265.4% | $2.9M |
| Total operating expenses | $78.7M+44.2% | $54.6M-6.7% | $58.5M-28.8% | $82.2M-46.8% | $154.3M |
| Operating loss | -$16.6M-270.8% | -$4.5M+74.0% | -$17.2M-190.5% | -$5.9M+83.2% | -$35.2M |
| Interest income (expense), net | $2.7M+453.3% | -$766K+45.5% | -$1.4M-395.1% | -$284K+41.4% | -$485K |
| Other income | $1.8M+267.4% | $494K-61.3% | $1.3M+92.6% | $662K+129.1% | $289K |
| Change in fair value of investments | $0+100.0% | -$4.1M | $0-100.0% | $697K | $0 |
| Gain on settlement of Global Cooling escrow | $0 | $0-100.0% | $5.1M | $0 | $0 |
| Total other income (expense), net | $4.5M+204.0% | -$4.3M-187.2% | $5.0M+363.6% | $1.1M-82.5% | $6.1M |
| Loss from continuing operations before income tax expense (benefit) | -$12.1M-36.9% | -$8.8M+27.8% | -$12.2M-152.1% | -$4.8M+83.3% | -$29.0M |
| Income tax expense (benefit) | $49K+228.9% | -$38K+40.6% | -$64K-101.2% | $5.2M-74.0% | $20.1M |
| Loss from continuing operations | -$12.1M-38.1% | -$8.8M+27.7% | -$12.2M-3233.2% | $388K | — |
| Income (loss) from discontinued operations before income tax expense | $7.5M+166.9% | -$11.3M+79.7% | -$55.6M+60.3% | -$140.0M | — |
| Income tax expense | $0-100.0% | $132K-43.3% | $233K+208.9% | -$214K | — |
| Income (loss) from discontinued operations | $7.5M+166.1% | -$11.4M+79.6% | -$55.8M+60.2% | -$140.2M | — |
| Net loss | -$4.6M+77.2% | -$20.2M+70.3% | -$68.0M+51.4% | -$139.8M-1469.4% | -$8.9M |
| Continuing operations (in dollars per share) | -$250-31.6% | -$190+32.1% | -$280-2900.0% | $10 | — |
| Discontinuing operations (in dollars per share) | $150+160.0% | -$250+80.3% | -$1K+61.5% | -$3K | — |
| Net loss (in dollars per share) | -$100+77.3% | -$440+71.6% | -$2K+52.9% | -$3K-1330.4% | -$230 |
| Basic (in shares) | $47.75B+3.7% | $46.07B+5.4% | $43.72B+2.9% | $42.48B+10.3% | $38.50B |
| Diluted (in shares) | $48.65B+5.6% | $46.07B+5.4% | $43.72B+1.5% | $43.07B+11.9% | $38.50B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum
BioLife (BLFS) Q1 2026 Earnings Transcript
BioLife Solutions, Inc. Q1 2026 Earnings Call Summary
Biolife outlines 2026 revenue of $112.5M-$115M while targeting full-year GAAP net income